Streptomycin: Difference between revisions
(added internal links) |
Ostermayer (talk | contribs) No edit summary |
||
| (8 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
==General== | ==General== | ||
*Type: [[ | *Type: [[Is DrugClass::Aminoglycoside]] | ||
*Dosage Forms: | *Dosage Forms: | ||
**IM | **IM | ||
| Line 8: | Line 8: | ||
===Infections, Bacterial=== | ===Infections, Bacterial=== | ||
*1-2 g/day IM divided q6-12h | *1-2 g/day IM divided q6-12h | ||
** Max: 2 g/day; Info: adjust dose based on serum levels | **Max: 2 g/day; Info: adjust dose based on serum levels | ||
**Renal dosing | **Renal dosing | ||
***Creatinine Clearance 50-80: give q24h | ***Creatinine Clearance 50-80: give q24h | ||
| Line 15: | Line 15: | ||
===Active [[tuberculosis]]=== | ===Active [[tuberculosis]]=== | ||
* | *15mg/kg IM q24h 5-7x/wk | ||
**Alternative: 25- | **Alternative: 25-30mg/kg IM 2-3x/wk | ||
===[[Plague]]=== | ===[[Plague]]=== | ||
| Line 29: | Line 29: | ||
===Infections, Bacterial=== | ===Infections, Bacterial=== | ||
*20- | *20-40mg/kg IM q24h | ||
**Alternative: 20- | **Alternative: 20-40mg/kg IM 2x/wk | ||
**Maximum dose: 1 g/dose if q24h, or 1.5 g/dose if 2x/wk | **Maximum dose: 1 g/dose if q24h, or 1.5 g/dose if 2x/wk | ||
**Renal dosing | **Renal dosing | ||
***Creatinine Clearance 50-80: 7. | ***Creatinine Clearance 50-80: 7.5mg/kg give q24h | ||
***Creatinine Clearance 10-50: 7. | ***Creatinine Clearance 10-50: 7.5mg/kg give q24-72h | ||
***Creatinine Clearance <10: 7. | ***Creatinine Clearance <10: 7.5mg/kg give q72-96h | ||
===Active [[tuberculosis]]=== | ===Active [[tuberculosis]]=== | ||
* 20- | *20-40mg/kg IM q24h | ||
**Alternative: 20- | **Alternative: 20-40mg/kg IM 2x/wk | ||
**Maximum dose: 1 g/dose if q24h, or 1.5 g/dose if 2x/wk | **Maximum dose: 1 g/dose if q24h, or 1.5 g/dose if 2x/wk | ||
===[[Plague]]=== | ===[[Plague]]=== | ||
* | *15mg/kg IM q12h x10 days | ||
**Maximum dose: 2 g/day (adjust dose based on serum levels) | **Maximum dose: 2 g/day (adjust dose based on serum levels) | ||
===[[Tularemia]]=== | ===[[Tularemia]]=== | ||
* | *15mg/kg IM q12h x10 days | ||
**Maximum dose: 2 g/day (adjust dose based on serum levels) | **Maximum dose: 2 g/day (adjust dose based on serum levels) | ||
| Line 54: | Line 54: | ||
*Lactation: Probably Safe | *Lactation: Probably Safe | ||
*Monitoring parameters: | *Monitoring parameters: | ||
**BUN/ | **BUN/creatinine at baseline, then periodically. | ||
**Serum drug levels | **Serum drug levels | ||
**Urinanalysis | **Urinanalysis | ||
| Line 89: | Line 89: | ||
*Anemia, hemolytic | *Anemia, hemolytic | ||
*Pancytopenia | *Pancytopenia | ||
*Thrombocytopenia | *[[Thrombocytopenia]] | ||
*Anaphylaxis | *[[Anaphylaxis]] | ||
*Angioedema | *Angioedema | ||
*Hypersensitivity reaction | *Hypersensitivity reaction | ||
| Line 100: | Line 100: | ||
*[[Vertigo]] | *[[Vertigo]] | ||
*Paresthesia, facial | *Paresthesia, facial | ||
*Rash | *[[Rash]] | ||
*Fever | *[[Fever]] | ||
*Urticaria | *[[Urticaria]] | ||
*[[Angioedema]] | *[[Angioedema]] | ||
*Eosinophilia | *Eosinophilia | ||
| Line 112: | Line 112: | ||
*Thrombocytopenia | *Thrombocytopenia | ||
*Pancytopenia | *Pancytopenia | ||
*Anemia, hemolytic | *[[Anemia]], hemolytic | ||
*muscle weakness | *muscle weakness | ||
*Amblyopia | *Amblyopia | ||
| Line 126: | Line 126: | ||
*[[Antibiotics (Main)]] | *[[Antibiotics (Main)]] | ||
== | ==References== | ||
<references/> | |||
Epocrates | Epocrates | ||
[[Category: | [[Category:Pharmacology]] | ||
[[Category:ID]] | |||
Latest revision as of 15:12, 18 July 2025
General
- Type: Aminoglycoside
- Dosage Forms:
- IM
Adult Dosing
Infections, Bacterial
- 1-2 g/day IM divided q6-12h
- Max: 2 g/day; Info: adjust dose based on serum levels
- Renal dosing
- Creatinine Clearance 50-80: give q24h
- Creatinine Clearance 10-50: give q24-72h
- Creatinine Clearance <10: give q72-96h
Active tuberculosis
- 15mg/kg IM q24h 5-7x/wk
- Alternative: 25-30mg/kg IM 2-3x/wk
Plague
- 1g IM q12h x10 days
- Maximum dose: 2 g/day (adjust dose based on serum levels)
Tularemia
- 1g IM q12h x10 days
- Maximum dose: 2 g/day (adjust dose based on serum levels)
Pediatric Dosing
Infections, Bacterial
- 20-40mg/kg IM q24h
- Alternative: 20-40mg/kg IM 2x/wk
- Maximum dose: 1 g/dose if q24h, or 1.5 g/dose if 2x/wk
- Renal dosing
- Creatinine Clearance 50-80: 7.5mg/kg give q24h
- Creatinine Clearance 10-50: 7.5mg/kg give q24-72h
- Creatinine Clearance <10: 7.5mg/kg give q72-96h
Active tuberculosis
- 20-40mg/kg IM q24h
- Alternative: 20-40mg/kg IM 2x/wk
- Maximum dose: 1 g/dose if q24h, or 1.5 g/dose if 2x/wk
Plague
- 15mg/kg IM q12h x10 days
- Maximum dose: 2 g/day (adjust dose based on serum levels)
Tularemia
- 15mg/kg IM q12h x10 days
- Maximum dose: 2 g/day (adjust dose based on serum levels)
Special Populations
- Pregnancy Rating: D
- Lactation: Probably Safe
- Monitoring parameters:
- BUN/creatinine at baseline, then periodically.
- Serum drug levels
- Urinanalysis
- Audiometry for high risk patients
Contraindications / Cautions
- Contraindicated:
- BCG live intravesical
- Cidofovir
- Streptozocin
- caution if hypersensitivity to sulfites
- caution if impaired vestibular function
- caution if impaired auditory function
- caution if concurrent ototoxic agents
- caution if concurrent neurotoxic agents
- caution if neuromuscular disease
- caution if renal impairment
- caution if dehydration
- caution if concurrent nephrotoxic agent use
- caution if electrolyte abnormalities
- caution if prolonged use
- caution in neonates or infants
- caution in elderly patients
Adverse Reactions
Serious
- Ototoxicity, auditory & vestibular
- Neurotoxicity
- Neuromuscular blockade
- Nephrotoxicity
- Anemia, hemolytic
- Pancytopenia
- Thrombocytopenia
- Anaphylaxis
- Angioedema
- Hypersensitivity reaction
- Exfoliative dermatitis
- Superinfection
Common
- Nausea and vomiting
- Vertigo
- Paresthesia, facial
- Rash
- Fever
- Urticaria
- Angioedema
- Eosinophilia
- Deafness
- Exfoliative dermatitis
- Anaphylaxis
- Azotemia
- Leukopenia
- Thrombocytopenia
- Pancytopenia
- Anemia, hemolytic
- muscle weakness
- Amblyopia
- Injection site reaction
Pharmacology
- Half-life: 5 hours
- Metabolism: Unknown; CYP450
- Excretion: Urine
- Mechanism of Action: Bactericidal (binds to 30S ribosomal subunit, inhibiting protein synthesis)
See Also
References
Epocrates
